Delta Asset Management’s Novo Nordisk NVO Stock Holding History

Delta Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.59K	Buy	200 +100	+100%	+$4.3K	﹤0.01%	441
2026 Q1	$3.67K	Buy	100 +40	+67%	+$1.9K	﹤0.01%	513
2025 Q4	$3.05K	Hold	60	–	–	﹤0.01%	524
2025 Q3	$3.33K	Hold	60	–	–	﹤0.01%	527
2025 Q2	$4.14K	Hold	60	–	–	﹤0.01%	501
2025 Q1	$4.17K	Hold	60	–	–	﹤0.01%	504
2024 Q4	$5.16K	Hold	60	–	–	﹤0.01%	493
2024 Q3	$7.14K	Hold	60	–	–	﹤0.01%	469
2024 Q2	$8.56K	Buy	60 +10	+20%	+$1.32K	﹤0.01%	457
2024 Q1	$6.42K	Buy	+50	New	+$5.95K	﹤0.01%	493
2014 Q4	–	Sell	-250	Closed	-$6K	–	573
2014 Q3	$6K	Sell	250 -50	-17%	-$1.15K	﹤0.01%	470
2014 Q2	$7K	Sell	300 -50	-14%	-$1.1K	﹤0.01%	470
2014 Q1	$8K	Sell	350 -190	-35%	-$4.05K	﹤0.01%	435
2013 Q4	$10K	Hold	540	–	–	﹤0.01%	407
2013 Q3	$9K	Hold	540	–	–	﹤0.01%	418
2013 Q2	$8K	Buy	+540	New	+$8.99K	﹤0.01%	434

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Delta Asset Management's NVO Position: Q2 2026 in Review

Delta Asset Management increased its Novo Nordisk (NVO) stake by 100% in Q2 2026, buying an estimated $4.3K and bringing the position to 200 shares worth $9.59K. The position accounts for ﹤0.01% of the portfolio, ranked #441.

Delta Asset Management first reported a position in NVO in Q2 2013 and has held it in 16 quarters since. The position peaked at $10K in Q4 2013. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Delta Asset Management held 200 shares of Novo Nordisk worth $9.59K as of Q2 2026.
Delta Asset Management bought 100 Novo Nordisk shares in Q2 2026, an estimated $4.3K.
Novo Nordisk made up ﹤0.01% of Delta Asset Management's portfolio in Q2 2026, its #441 holding.
Delta Asset Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 16 quarters since.
Delta Asset Management's Novo Nordisk position peaked at $10K in Q4 2013.
1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Delta Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.